Skip to content
Lower risk Medical device recall · FDA · Published December 18, 2017

Phadia ImmunoCAP Allergen c5 Ampicilloyl Recall: Stability Issues

Phadia recalls ImmunoCAP Allergen c5 Ampicilloyl (article 14-4450-01) due to stability problems. This affects specific IgE test kits with lot numbers 990DS through 990DY.

🇺🇸 FDA recall #Z-1312-2018Medical devicePhadia ›
Take action

Contact the company

Recalling firmPhadia US Inc4169 Commercial Ave · Portage, MI 49002-9701
✎ GovInfoNow plain-language explainer

What happened, in plain English

Phadia is recalling ImmunoCAP Allergen c5 Ampicilloyl test kits because they may not meet stability requirements. This could lead to inaccurate allergy test results if used after the expiration date. Read more at govinfonow.com/recall/72295-phadia-immunocap-allergen-c5-ampicilloyl-recall-stability-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/72295-phadia-immunocap-allergen-c5-ampicilloyl-recall-stability-issues · Updated August 31, 2026 · FDA enforcement record: FDA #Z-1312-2018

Cite this page

“Phadia ImmunoCAP Allergen c5 Ampicilloyl Recall: Stability Issues.” GovInfoNow, updated August 31, 2026. https://govinfonow.com/recall/72295-phadia-immunocap-allergen-c5-ampicilloyl-recall-stability-issues. Based on FDA recall #Z-1312-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1312-2018%22&limit=1).

Why it’s dangerous

The test kits may not meet stability specifications, meaning they could become inaccurate after the expiration date. This could lead to incorrect allergy test results if used beyond their expiration dates.

Who’s affected

People who own or use ImmunoCAP Allergen c5 Ampicilloyl test kits with lot numbers 990DS through 990DY are affected. Those using these kits for allergy testing are most at risk of inaccurate results.

How to tell if you have this one

Check the lot number on the test kit, which is listed as 990DS, 990DT, 990DW, 990DX, or 990DY. These kits were sold with expiration dates up to December 31, 2017, through May 31, 2018.

  • Brand
    Phadia
  • Category
    Medical device
FDA recall event · 2 products

All 2 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Nationwide Distribution
Recall numberProduct, codes & lots
Z-1312-2018ImmunoCAP Allergen c5, Ampicilloyl (article number 14-4450-01). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma. To be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.; Lots 990DS, Exp 2017.12.31 990DT, Exp 2018.01.31 990DW, Exp 2018.03.31 990DX, Exp, 2018.05.31 990DY
Z-1313-2018ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma; to be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.; Lots 991DA, exp.2018.04.30 991DC, exp. 2018.07.31 991D7 991D9, exp.2018.02.28
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Expiration

    Look for the lot number on the test kit to confirm it is one of 990DS, 990DT, 990DW, 990DX, or 990DY.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide Distribution” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 15 months after the firm started it.

1. Firm started the recall: Dec 18, 201712. FDA classified it Class II: Apr 5, 201823. Published in FDA’s Enforcement Report: Apr 11, 201834. FDA terminated the recall: Mar 27, 2019420172019
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1312-2018 (December 18, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1312-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on August 31, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA